BEIGENE (06160) intends to change its English name to "BeOne Medicines Ltd."
Baiji Shenzhou (06160) issued an announcement regarding the continuation of the company, the board of directors proposes to change the company's English name from "BeiG...
BEIGENE (06160) announced that for the purpose of continuity, the board of directors proposes to change the company's English name from "BeiGene, Ltd." to "BeOne Medicines Ltd." and adopt a proposed Swiss Articles of Association that includes the proposed company name change. The company's Chinese name will remain unchanged.
The announcement stated that the new English name reflects the company's commitment to developing innovative drugs and working with stakeholders globally to serve more patients and eliminate cancer. The board believes that the proposed company name change is in the overall interest of the company and shareholders.
Related Articles

CHINA INFO TECH (08178) announced its annual performance, with a net loss attributable to shareholders of HK$99.459 million for the year, representing a 164.28% increase compared to the previous year.

BRIGHTSTAR TECH (08446) announces its annual performance for 2025, with a net profit attributable to shareholders of HK$25,949,000, a decrease of 38.7% compared to the previous year.

Ming Liang Holdings (08152) announced its 2025 performance, with a profit attributable to equity holders of HK$9.426 million, turning losses into profits year on year.
CHINA INFO TECH (08178) announced its annual performance, with a net loss attributable to shareholders of HK$99.459 million for the year, representing a 164.28% increase compared to the previous year.

BRIGHTSTAR TECH (08446) announces its annual performance for 2025, with a net profit attributable to shareholders of HK$25,949,000, a decrease of 38.7% compared to the previous year.

Ming Liang Holdings (08152) announced its 2025 performance, with a profit attributable to equity holders of HK$9.426 million, turning losses into profits year on year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


